Flare Therapeutics
PrivateLast Round
Series C
Jun 30, 2026
Est. Valuation
$161.62M
Total Funding Raised
$290M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Flare Therapeutics is a biotechnology company that develops small-molecule precision medicines targeting transcription factors for the treatment of cancer and other severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flare Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Flare Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 30, 2026 | ||||
| Series B | Mar 22, 2023 | ||||
| Series A | May 13, 2021 |
Key People
Founding team and executive leadership
Flare Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series C, Series B |
| Boxer Capital | Series A, Series C, Series B |
| GordonMD Global Investments | Series C, Series B |
| Eventide Funds | Series B, Series A, Series C |
| Invus Opportunities | Series B, Series A, Series C |
| Pavilion Capital | Series B |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
$85M round led by Nextech Invest and Third Rock Ventures.
- Apr 6, 2026
Presenting three posters at the AACR Annual Meeting 2026.
Flare Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Flare Therapeutics's valuation, stock price, and market status.